[Artificial intelligence in the management of anti-VEGF treatment: the Vienna fluid monitor in clinical practice].
P FuchsL CoulibalyG S ReiterUrsula Margarethe Schmidt-ErfurthPublished in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft (2022)
The Vienna fluid monitor is an artificial intelligence (AI) algorithm for the precise localization and quantification of retinal fluid. The algorithm is designed to help clinicians to make objective and accurate decisions in the anti-vascular endothelial growth factor (anti-VEGF) therapy of patients with neovascular age-related macular degeneration. The goal of the implementation is to optimize patient safety, preserve visual function and simultaneously to reduce the treatment burden on the healthcare system and patients.
Keyphrases
- artificial intelligence
- vascular endothelial growth factor
- machine learning
- deep learning
- patient safety
- age related macular degeneration
- big data
- endothelial cells
- end stage renal disease
- clinical practice
- quality improvement
- primary care
- ejection fraction
- newly diagnosed
- chronic kidney disease
- palliative care
- prognostic factors
- stem cells
- high resolution
- peritoneal dialysis
- combination therapy
- risk factors